Covestor LTD Abb Vie Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Covestor LTD holds 1,367 shares of ABBV stock, worth $244,966. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,367

Previous 1,307 4.59%

Holding current value

$244,966

Previous $224,000 20.54%

% of portfolio

0.17%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$163.84 - $199.33 $9,830 - $11,959	60 Added 4.59%	1,367 $270,000
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $6,191 - $7,230	-40 Reduced 2.97%	1,307 $224,000
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $15,342 - $17,481	-96 Reduced 6.65%	1,347 $245,000
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $4,816 - $5,423	35 Added 2.49%	1,443 $223,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $22,042 - $25,517	-165 Reduced 10.49%	1,408 $210,000
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $15,371 - $19,128	-116 Reduced 6.87%	1,573 $212,000
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $22,414 - $25,813	155 Added 10.1%	1,689 $269,000
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $104,424 - $125,231	755 Added 96.92%	1,534 $248,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $198,093 - $227,200	-1,476 Reduced 65.45%	779 $104,000
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $71,149 - $90,454	517 Added 29.75%	2,255 $345,000
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $36,822 - $45,686	279 Added 19.12%	1,738 $282,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $156,740 - $198,321	1,459 New	1,459 $198,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account